BioMarin Pharmaceutical
BMRN
#1728
Rank
โ‚น1.106 T
Marketcap
โ‚น5,714
Share price
-0.02%
Change (1 day)
22.86%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2026 (TTM): -โ‚น8.73

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is -โ‚น8.37. In 2025 the company made an earnings per share (EPS) of โ‚น169.31 a decrease over its 2024 EPS that were of โ‚น209.32.

EPS history for BioMarin Pharmaceutical from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น8.73-105.16%
2025โ‚น169.31-19.11%
2024โ‚น209.32152.81%
2023โ‚น82.8015.79%
2022โ‚น71.51-319.62%
2021-โ‚น32.56-107.38%
2020โ‚น440.96-3485.71%
2019-โ‚น13.02-67.44%
2018-โ‚น40.00-34.85%
2017-โ‚น61.40-83.21%
2016-โ‚น365.61263.89%
2015-โ‚น100.4718.68%
2014-โ‚น84.66
2012-โ‚น88.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น184.25-2,300.59%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น482.83 5,666.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น35.35 322.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น1.86-77.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น10.23 22.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น168.38-2,111.11%๐Ÿ‡บ๐Ÿ‡ธ USA